Fundraising Fox

Neuronascent

Clarksville, US · Maryland corporation

NeuroNascent develops therapeutics aimed at generating new neurons and regenerating existing ones to treat neurological disorders. Its R&D pipeline targets conditions including Alzheimer's disease, Parkinson's disease, and developmental delay, alongside a veterinary medicine program.

Founders & leadership

JK
Judith Kelleher-AnderssonFounder
KM
Kathleen MattisExecutive

Board

RO
Robin OegerleBoard director
MG
Maurice GagnonBoard director

Reported raises · per SEC filings

Form D private placements

$1.2M disclosed across 1 round · 2015

$1.2MraisedMar 2015 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robin OegerleDirector
  • Maurice GagnonDirector
  • Judith Kelleher-AnderssonExecutive Officer, Director
  • Kathleen MattisExecutive Officer, Director
Offering amount
$3M
Amount sold
$1.2M
Minimum investment
$112.5K
First sale
Mar 2015
Incorporated
Corporation, Maryland
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with Neuronascent for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Neuronascent do?
NeuroNascent develops therapeutics aimed at generating new neurons and regenerating existing ones to treat neurological disorders. Its R&D pipeline targets conditions including Alzheimer's disease, Parkinson's disease, and developmental delay, alongside a veterinary medicine program.
Who founded Neuronascent?
Neuronascent was founded by Judith Kelleher-Andersson.
How much funding has Neuronascent raised?
Neuronascent has disclosed $1.2M raised across 1 round.
Where is Neuronascent headquartered?
Neuronascent is headquartered in Clarksville, US.